UK markets closed
  • FTSE 100

    7,486.67
    +20.07 (+0.27%)
     
  • FTSE 250

    19,545.70
    +5.36 (+0.03%)
     
  • AIM

    847.07
    +2.68 (+0.32%)
     
  • GBP/EUR

    1.1629
    -0.0005 (-0.04%)
     
  • GBP/USD

    1.2097
    -0.0017 (-0.14%)
     
  • BTC-GBP

    13,705.15
    -21.95 (-0.16%)
     
  • CMC Crypto 200

    386.97
    +4.32 (+1.13%)
     
  • S&P 500

    4,026.12
    -1.14 (-0.03%)
     
  • DOW

    34,347.03
    +152.97 (+0.45%)
     
  • CRUDE OIL

    76.28
    -1.66 (-2.13%)
     
  • GOLD FUTURES

    1,754.00
    +8.40 (+0.48%)
     
  • NIKKEI 225

    28,283.03
    -100.06 (-0.35%)
     
  • HANG SENG

    17,573.58
    -87.32 (-0.49%)
     
  • DAX

    14,541.38
    +1.82 (+0.01%)
     
  • CAC 40

    6,712.48
    +5.16 (+0.08%)
     

DNA Plc’s financial information and Annual General Meeting in 2023

DNA Oyj
DNA Oyj

DNA PLC STOCK EXCHANGE RELEASE 16 November 2022, 10:00 am EET

In 2023, DNA will publish its financial statements, semi-annual report and business reviews sent as press releases as follows:

  • 2 February 2023: Financial statements bulletin for 2022

  • 4 May 2023: January–March 2023 business review as a press release

  • 20 July 2023: Half year (January–June) 2023 financial report

  • 25 October 2023: January–September 2023 business review as a press release

DNA’s electronic annual report, which contains the complete Financial Statements 2022, will be published at the latest during the week starting from 6 March 2023 (week 10/2023).

DNA's Annual General Meeting is planned to be held on 30 March 2023.

Further information:
Timo Kipinoinen, CFO (acting), DNA Plc, tel. +358 (0) 44 044 8131, timo.kipinoinen@dna.fi
DNA Corporate Communications, tel. +358 44 044 8000, communications@dna.fi